Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.

AIMS: Ivabradine has been approved in heart failure with reduced ejection fraction (HFrEF) and elevated heart rate despite guideline‐directed medical therapy (GDMT) to reduce cardiovascular (CV) death and hospitalization for worsening HF. The median value of 77 b.p.m. is the lower bound selected for...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:ESC Heart Fail
Egile Nagusiak: Bouabdallaoui, Nadia, O'Meara, Eileen, Bernier, Virginie, Komajda, Michel, Swedberg, Karl, Tavazzi, Luigi, Borer, Jeffrey S., Bohm, Michael, Ford, Ian, Tardif, Jean‐Claude
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2019
Gaiak:
Original Research Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6989297/
https://ncbi.nlm.nih.gov/pubmed/31591826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12513
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak